EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers

Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, Alberto Pugliese, Hemang M Parikh, William W Kwok, Terry P Lybrand, George P Bondinas, Antonis K Moustakas, Ruihan Wang, Chul-Woo Pyo, Wyatt C Nelson und 2 weitere

Diabetologia · 2024

DOI: 10.1007/s00125-024-06274-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Lue Ping Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, HLA-DQ alpha-Chains, HLA-DQ beta-Chains, Haplotypes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Lund University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis The aim of this work was to explore molecular amino acids (AAs) and related structures of HLA-DQA1-DQB1 that underlie its contribution to the progression from stages 1 or 2 to stage 3 type 1 diabetes.

Methods

Using high-resolution DQA1 and DQB1 genotypes from 1216 participants in the Diabetes Prevention Trial-Type 1 and the Diabetes Prevention Trial, we applied hierarchically organised haplotype association analysis (HOH) to decipher which AAs contributed to the associations of DQ with disease and their structural properties. HOH relied on the Cox regression to quantify the association of DQ with time-to-onset of type 1 diabetes.

Results

By numerating all possible DQ heterodimers of α- and β-chains, we showed that the heterodimerisation increases genetic diversity at the cellular level from 43 empirically observed haplotypes to 186 possible heterodimers. Heterodimerisation turned several neutral haplotypes ( DQ2.2 , DQ2.3 and DQ4.4 ) to risk haplotypes ( DQ2.2/2.3-DQ4.4 and DQ4.4-DQ2.2 ). HOH uncovered eight AAs on the α-chain (−16α, −13α, −6α, α22, α23, α44, α72, α157) and six AAs on the β-chain (−18β, β9, β13, β26, β57, β135) that contributed to the association of DQ with progression of type 1 diabetes. The specific AAs concerned the signal peptide (minus sign, possible linkage to expression levels), pockets 1, 4 and 9 in the antigen-binding groove of the α1β1 domain, and the putative homodimerisation of the αβ heterodimers. Conclusions/interpretation These results unveil the contribution made by DQ to type 1 diabetes progression at individual residues and related protein structures, shedding light on its immunological mechanisms and providing new leads for developing treatment strategies. Data availability Clinical trial data and biospecimen samples are available through the National Institute of Diabetes and Digestive and Kidney Diseases Central Repository portal ( https://repository.niddk.nih.gov/studies ). Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HLA-DQ alpha-ChainsHLA-DQ beta-ChainsHaplotypesDisease ProgressionHumansFemaleMaleGenetic Predisposition to DiseaseGenotypeProtein Multimerization

Stichwörter der Autor:innen

Amino acidsHLAImmunogeneticsIslet autoimmunityProgressionSeroconversionType 1 diabetes

Substanzen

HLA-DQ alpha-ChainsHLA-DQ beta-ChainsHLA-DQA1 antigenHLA-DQB1 antigen

Autor:innen und Institutionen

  • Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • School of Public Health, University of Washington, Seattle, WA, USA.
  • Laboratory of Biophysics, Biochemistry, Biomaterials and Bioprocessing, Faculty of Agricultural Technology, Technological Educational Institute (TEI) of Epirus, Arta, Greece.
  • Diabetes Research Institute and Division of Endocrinology, Diabetes & Metabolism, University of Miami Miler School of Medicine, Miami, FL, USA.
  • Department of Diabetes Immunology, City of Hope, South Pasadena, CA, USA.
  • Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Lund University

Zitieren

APA

Zhao, L. P., Papadopoulos, G. K., Skyler, J. S., Pugliese, A., Parikh, H. M., Kwok, W. W., Lybrand, T. P., Bondinas, G. P., Moustakas, A. K., Wang, R., Pyo, C. W., Nelson, W. C., Geraghty, D. E., & Lernmark, Å. (2024). Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers. Diabetologia. https://doi.org/10.1007/s00125-024-06274-6

Vancouver

Zhao LP, Papadopoulos GK, Skyler JS, Pugliese A, Parikh HM, Kwok WW, et al. Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers. Diabetologia. 2024. doi:10.1007/s00125-024-06274-6

BibTeX
@article{Zhao2024,
  author = {Zhao, Lue Ping and Papadopoulos, George K and Skyler, Jay S and Pugliese, Alberto and Parikh, Hemang M and Kwok, William W and Lybrand, Terry P and Bondinas, George P and Moustakas, Antonis K and Wang, Ruihan and Pyo, Chul-Woo and Nelson, Wyatt C and Geraghty, Daniel E and Lernmark, Åke},
  title = {Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06274-6}
}
Kostenlos starten →